Global Syringes (Disposable and Reusable) Industry

  • June 2014
  • -
  • Global Industry Analysts
  • -
  • 348 pages

This report analyzes the worldwide markets for Syringes (Disposable and Reusable) in US$ Thousands by the following Product Segments: Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes (Prefilled Syringes, & Other Hypodermic Syringes), Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 109 companies including many key and niche players such as -

Abbott Laboratories, Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Covidien
C. R. Bard, Inc.

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Definition of Product Segments I-3
Anesthesia Syringes I-3
Angiographic Syringes I-4
Blood Gas Syringes I-4
Catheter Syringes I-4
Dental Syringes I-4
Ear Syringes I-4
Hypodermic Syringes I-4
Prefilled Syringes I-5
Other Hypodermic Syringe I-5
Insulin Syringes I-5
Intraligamentary Syringes I-5
Irrigating Syringes I-5


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1
Prelude II-1
Reusables and Disposables: Drawing a Parallel II-2
Impact of Healthcare Budget Cuts II-2
Table 1: Elderly Healthcare Expenditure as a % of GDP
(includes corresponding Graph/Chart) II-4
Improving Healthcare Expenditure Turbo Charges Demand II-4
Table 2: Healthcare Spending as a Percentage of GDP (2012)
(includes corresponding Graph/Chart) II-5
A Review of Long-term Growth Drivers II-6
Demographics Spell Opportunities II-6
Table 3: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-7

Table 4: Elderly Population (60+ Years) as a Percentage of
the Total Population (2012 and 2050) (includes corresponding
Graph/Chart) II-8

Table 5: Global Aging Population by Age Group: 1975-2050
(includes corresponding Graph/Chart) II-8
Table 6: Aging Population by Age Group in More Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-9
Table 7: Aging Population by Age Group in Less Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-10
Table 8: Aging Population by Age Group in Least Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-11

Table 9: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) and (2045-2050) (includes
corresponding Graph/Chart) II-12
Diabetics: Major End-Users of Syringes II-12
Table 10: Worldwide Prevalence of Diabetes Mellitus by
Region (2013 and 2035P) (includes corresponding Graph/Chart) II-13

Table 11: Incidence of Diabetes in Select Countries (2013 and
2035) (includes corresponding Graph/Chart) II-14

Table 12: Global Insulin Delivery Devices Market by Segment
(2013E): Percent Share Breakdown of Value Sales for Insulin
Pumps, Insulin Pens and Insulin Syringes (includes
corresponding Graph/Chart) II-15

Table 13: Global Insulin Delivery Devices Market by Leading
Players (2013): Percentage Market Share Breakdown for
Medtronic, Novo Nordisk, Sanofi and Others (includes
corresponding Graph/Chart) II-15
Needlestick Injuries - A Menace in Healthcare Environment II-15
Focus on Prevention of HAIs II-16
Asia - Focal Point for Future Growth II-17
Competitive Scenario II-17
A Relatively Concentrated Market II-17
Table 14: Leading Players in the Global Traditional Syringe
Market (2012): Percentage Breakdown of Value Sales for
Becton, Dickinson and Co, Covidien, Retractable
Technologies, Terumo and Others (includes corresponding
Graph/Chart) II-18

Table 15: Leading Players in the Global Safety Syringe
Market (2012): Percentage Breakdown of Becton, Dickinson and
Co, Covidien, Retractable Technologies, Terumo and Others
(includes corresponding Graph/Chart) II-18
List of Select Products in the Global Syringe Market II-19
Global Prefilled Syringe Market: Strong Consolidation Activity II-19
Table 16: Leading Players in the Global Prefilled Syringe
Market (2012): Percentage Breakdown of Revenues for B Braun,
Baxter BioPharma, Becton Dickinson, Gerresheimer, Owen
Mumford, Schott AG, Terumo, West Pharmaceuticals, Ypsomed
and Others (includes corresponding Graph/Chart) II-20
Competitive Scenario in the Biologics market II-20

2. MARKET TRENDS and ISSUES II-21
Technological Advancements Drive the Market for Syringes II-21
Demand for Safety Syringes on the Rise II-21
Government Regulations Drive Demand for Safety Syringes II-22
Markets Crave for Further Advancements in Safety Syringes II-22
Ready-to-Fill Segment Goes Strong II-23
Prefilled Syringes - Emerging Trend II-23
Table 17: Global Prefilled Syringes Market (2012): Percentage
Share Breakdown of Consumption by Therapeutic Area -
Anaphylaxis, Anti-Coagulants, Diabetes, Growth Hormone,
Vaccines, and Others (includes corresponding Graph/Chart) II-23
Bubble-Free Filling - A New Method of Filling Solution in
Prefilled Syringes II-24
Ionizing Radiation - Preferred Method of Sterilizing
Prefilled Syringes II-24
Self-Injection Devices - Growing Market II-24
Prefilled Syringe Pen Injectors - A New Kind of Autoinjector
System II-25
List of Select Prefilled Syringe Pen Injectors Available in
the Market II-25
Human Factors Influencing the Design of Self Injection Systems II-26
Dental Syringes Market - Going Strong II-26
Disposable Syringes - Widely Adopted II-26
Traditional Needles and Syringes Market to Contract II-27
Shift from Glass to Plastic II-27
Change in Syringe Materials - Growing Emphasis on Value Addition II-27
Ongoing Research to Further Advance Delivery Systems Fuels
Market Growth II-28
Innovations in Hypodermic Needles Segment II-28
Color Changing Syringes: A Means to Prevent Contamination II-28
Drug Delivery Technology - Driven by Targeted Drug Delivery II-29
Technological Advancements for Customized Drug Delivery Systems II-29
Parenteral Drug Delivery: Opportunities for Pre-filled
Syringes Market II-30
Pricing Trends II-30
Disposal of Syringes - A Primary Issue II-30
Needleless Systems Pose Threat to Traditional Syringes II-31
Alternative to Syringes - Potential Threats II-32
Insulin Infusion Pumps II-32
Preloaded Insulin Pens II-32
Pulmonary Drug Delivery II-32

3. PRE-FILLED SYRINGES MARKET - AN INSIGHT II-33
Prefilled Syringes: The Preferred Drug Delivery Device II-33
Factors favoring prefilled injections market II-34
Prefilled Syringes - Benefiting All Stakeholders II-35
Ease of Use - Favoring Adoption of Prefilled Syringes II-35
Convenience in Manufacture and Reduced Overfill: Benefits to
Manufacturers II-35
Glass Vs Plastic in Prefilled Syringes II-36
Advancements in Prefilled Syringes Driving Momentum in the Market II-36
Barrier Systems II-36
Handling II-36
Filling and Stoppering II-37
Prefilled Safety Syringes: Preventing Blood Borne Infections II-37
Dual/Multi-Chamber Syringes: Gaining Prominence in the
Prefilled Syringes Market II-38
Silicone-free Prefilled Syringes: Avoiding Disadvantages of
Silicone Lubrication II-39
Product Design and Trends II-39
Advantages of Prefilled Syringes Cartridges II-40
Concerns - The Other Side II-40

4. PRODUCT OVERVIEW II-41
Syringes II-41
Disposable Syringe II-41
Reusable Syringe II-41
Product Segments II-41
Anesthesia Syringes II-41
Angiographic Syringes II-41
Blood Gas Syringes II-41
Catheter Syringes II-42
Dental Syringes II-42
Ear Syringes II-42
Hypodermic Syringes II-42
Insulin Syringes II-42
Intraligamentary Syringes II-43
Irrigating Syringes II-43
Facts About Needlesticks II-43

5. PRODUCT INTRODUCTIONS/APPROVALS II-44
Hamilton Launches AcidLine Syringes II-44
Kyowa Hakko Kirin Introduces NESP® Injection 5 µg Plastic
Syringe in Japan II-44
BD Medical Introduces New BD Sterifill Advanceâ„¢ 50 ML II-44
DMC Medical Introduces NuGenâ„¢ syringes Range II-44
SCHOTT North America Launches TopPac® 20 ml Prefillable
Polymer Syringe II-44
DUX Dental Launches ZONEfree syringe II-44
Daiichi Sankyo Introduces PRALIA® Subcutaneous Injection 60mg
Syringe II-45
BD Introduces BD Glide 6mm Needle II-45
Roselabs Bioscience to Introduce PFL syringes II-45
BD Medical Introduces BD Sterifill Advance II-45
BD Medical Introduces BD Neopakâ„¢ Prefillable Syringe System II-45
Mallinckrodt Obtains FDA Approval for New Gablofen® Prefilled
Syringe II-45
West Pharmaceutical Services Introduces B.safe Syringe Safety
System II-45
Norgren Launches Inline Pump With Replaceable Syringe II-45
Globe Medical Tech Launches Safety Prefillable Syringe System II-46
RephiLe Bioscience Introduces New RephiQuik Syringe Filters II-46
BD to Introduce Single Lock-in Syringes in India II-46
Zahoransky Develops Fully Automated Production Line for
Disposable Syringes II-46

6. RECENT INDUSTRY ACTIVITY II-47
Medtronic to Acquire Covidien II-47
Hikma Pharmaceuticals and Unilife Corporation Enter into
Supply Agreement II-47
Aesica Expands Manufacturing Capabilities II-47
Covidien Recalls Monojectâ„¢ Prefill Flush Syringes II-47
Roselabs Bioscience and Roselabs Polymers Set up a Pre-Filled
Syringe Manufacturing Unit II-47
SCHOTT AG Expands its Production Capacity II-47
BD Takes Over Safety Syringes II-48
Bracco Diagnostics Recalls Isovue® Pre-Filled Power Injector
Syringes II-48
INJEX Pharma AG and American Healthcare Products Enter into
Distribution Agreement II-48

7. FOCUS ON SELECT GLOBAL PLAYERS II-49
Abbott Laboratories, Inc. (US) II-49
B. Braun Melsungen AG (Germany) II-49
Becton, Dickinson and Company (US) II-49
Covidien (Ireland) II-50
C. R. Bard, Inc. (US) II-50
Kawamoto Corporation (Japan) II-50
Medline Industries Inc. (US) II-51
Merit Medical Systems, Inc. (US) II-51
Smiths Medical (UK) II-51
Terumo Corp. (Japan) II-52
Terumo Medical Corporation (US) II-52

8. GLOBAL MARKET PERSPECTIVE II-53
Table 18: World Recent Past, Current and Future Analysis for
Syringes (Disposable and Reusable) by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East and Latin America Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) II-53

Table 19: World Historic Review for Syringes (Disposable and
Reusable) by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-54

Table 20: World 15-Year Perspective for Syringes (Disposable
and Reusable) by Geographic Region - Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) II-55

Table 21: World Recent Past, Current and Future Analysis for
Anesthesia Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-56

Table 22: World Historic Review for Anesthesia Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-57

Table 23: World 15-Year Perspective for Anesthesia Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-58

Table 24: World Recent Past, Current and Future Analysis for
Angiographic Syringes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-59

Table 25: World Historic Review for Angiographic Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-60

Table 26: World 15-Year Perspective for Angiographic Syringes
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-61

Table 27: World Recent Past, Current and Future Analysis for
Blood Gas Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-62

Table 28: World Historic Review for Blood Gas Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-63

Table 29: World 15-Year Perspective for Blood Gas Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-64

Table 30: World Recent Past, Current and Future Analysis for
Catheter Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-65

Table 31: World Historic Review for Catheter Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-66

Table 32: World 15-Year Perspective for Catheter Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-67

Table 33: World Recent Past, Current and Future Analysis for
Dental Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-68

Table 34: World Historic Review for Dental Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-69

Table 35: World 15-Year Perspective for Dental Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-70

Table 36: World Recent Past, Current and Future Analysis for Ear
Syringes by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-71

Table 37: World Historic Review for Ear Syringes by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) II-72

Table 38: World 15-Year Perspective for Ear Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-73

Table 39: World Recent Past, Current and Future Analysis for
Hypodermic Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-74

Table 40: World Historic Review for Hypodermic Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-75

Table 41: World 15-Year Perspective for Hypodermic Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-76

Table 42: World Recent Past, Current and Future Analysis for
Hypodermic Syringes by Type - Prefilled and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-77

Table 43: World Historic Review for Hypodermic Syringes by
Type - Prefilled and Others Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) II-78

Table 44: World 15-Year Perspective for Hypodermic Syringes by
Type - Percentage Breakdown of Dollar Sales for Prefilled and
Others Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) II-79

Table 45: World Recent Past, Current and Future Analysis for
Prefilled Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-80

Table 46: World Historic Review for Prefilled Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-81

Table 47: World 15-Year Perspective for Prefilled Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-82

Table 48: World Recent Past, Current and Future Analysis for
Other Hypodermic Syringes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-83

Table 49: World Historic Review for Other Hypodermic Syringes
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-84

Table 50: World 15-Year Perspective for Other Hypodermic
Syringes by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East and Latin America Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) II-85

Table 51: World Recent Past, Current and Future Analysis for
Insulin Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-86

Table 52: World Historic Review for Insulin Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-87

Table 53: World 15-Year Perspective for Insulin Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-88

Table 54: World Recent Past, Current and Future Analysis for
Intraligamentary Syringes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-89

Table 55: World Historic Review for Intraligamentary Syringes
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-90

Table 56: World 15-Year Perspective for Intraligamentary
Syringes by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East and Latin America Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) II-91

Table 57: World Recent Past, Current and Future Analysis for
Irrigating Syringes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-92

Table 58: World Historic Review for Irrigating Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-93

Table 59: World 15-Year Perspective for Irrigating Syringes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-94


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Outlook III-1
Healthcare Spending the US III-1
Table 60: US Market by Drug Delivery Type (2013E):
Percentage Breakdown of Spending for Oral, Injectables and
Others (includes corresponding Graph/Chart) III-1
Needle Stick Injuries III-2
Table 61: Needle Stick injuries in both Acute and Non-acute
Healthcare Facilities in the US (2012): Percentage
Breakdown of Injuries Depending on the Phase of Treatment
(includes corresponding Graph/Chart) III-2

Table 62: Distribution of Sharp-Related Injuries in the US
by the Presence of Prevention Features (2012) (includes
corresponding Graph/Chart) III-2

Table 63: Percutaneous Injuries by Type of Device (2012):
Percentage Breakdown of Number of Devices for Hollow-bore
needle (Hypodermic needle, Winged-steel needle, IV stylet,
Phlebotomy needle and Other hollow-bore needle), Solid
Sharps (Suture needle, Scalpet, and Others), Glass and
Unknown (includes corresponding Graph/Chart) III-3
Disposable Syringes Market: Competitive Landscape III-3
Safety Syringes Report Healthy Growth III-4
Prefilled Syringes - Another Growing Market III-4
Insulin Syringes Dominate the US Insulin Delivery Devices
Market III-4
Table 64: The US Insulin Delivery Devices Market by Segment
(2013E): Percent Share Breakdown of Consumption for Insulin
Syringes, Insulin Pumps, and Insulin Pens (includes
corresponding Graph/Chart) III-5
Diabetes Statistics in the US - An Overview III-5
Table 65: North American and Caribbean Regional Population
and Diabetes Prevalence Statistics (2013E) - Top Regions
with High Prevalence of Diabetes by Age Group and Gender
(includes corresponding Graph/Chart) III-6

Table 66: Number of Diabetics by Gender in the US (2013E)
(in ‘000s) (includes corresponding Graph/Chart) III-7

Table 67: Number of Diabetics in the US by Age Group
(2013E) (in ‘000s) (includes corresponding Graph/Chart) III-7

Table 68: US Market for Diabetes (2012): Percentage
Breakdown of Prevalence by Race/Ethnicity - Non-Hispanic
Blacks and Non-Hispanic Whites (includes corresponding
Graph/Chart) III-7
Patient Protection and Affordable Care Act III-7
Export-Import Statistics III-8
Table 69: US Exports of HS 901831 Syringes (2012 and 2013):
Percentage Share Breakdown of Export Value by Country of
Destination (includes corresponding Graph/Chart) III-8

Table 70: US Imports of HS 901831 Syringes (2012 and 2013):
Percentage Share Breakdown of Import Value by Country of
Origin (includes corresponding Graph/Chart) III-9
Product Launches/Innovations III-9
Strategic Corporate Developments III-11
Select Players III-11
B.Market Analytics III-14
Table 71: US Recent Past, Current and Future Analysis for
Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-14

Table 72: US Historic Review for Syringes (Disposable and
Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-15

Table 73: US 15-Year Perspective for Syringes (Disposable
and Reusable) by Product Segment - Percentage Breakdown of
Dollar Sales for Anesthesia Syringes, Angiographic Syringes,
Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear
Syringes, Hypodermic Syringes, Insulin Syringes,
Intraligamentary Syringes, and Irrigating Syringes Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-16

Table 74: US Recent Past, Current and Future Analysis for
Hypodermic Syringes by Type - Prefilled and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-17

Table 75: US Historic Review for Hypodermic Syringes by Type
- Prefilled and Others Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-18

Table 76: US 15-Year Perspective for Hypodermic Syringes by
Type - Percentage Breakdown of Dollar Sales for Prefilled
and Others Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-19

2. CANADA III-20
A.Market Analysis III-20
Outlook III-20
Export - Import Statistics III-20
Table 77: Canadian Exports of HS 901831 Syringes (2012 and
2013): Percentage Share Breakdown of Export Value by
Country of Destination (includes corresponding Graph/Chart) III-20

Table 78: Canadian Imports of HS 901831 Syringes (2012 and
2013): Percentage Share Breakdown of Import Value by
Country of Origin (includes corresponding Graph/Chart) III-21
B.Market Analytics III-22
Table 79: Canadian Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-22

Table 80: Canadian Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-23

Table 81: Canadian 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-24

Table 82: Canadian Recent Past, Current and Future Analysis
for Hypodermic Syringes by Type - Prefilled and Others
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-25

Table 83: Canadian Historic Review for Hypodermic Syringes
by Type - Prefilled and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-26

Table 84: Canadian 15-Year Perspective for Hypodermic
Syringes by Type - Percentage Breakdown of Dollar Sales for
Prefilled and Others Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-27

3. JAPAN III-28
A.Market Analysis III-28
Outlook III-28
List of Select Drugs Approved for Prefilled Syringes in
Japan (2007-2012) III-28
Product Launches III-29
Key Players III-29
B.Market Analytics III-30
Table 85: Japanese Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-30

Table 86: Japanese Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-31

Table 87: Japanese 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-32

Table 88: Japanese Recent Past, Current and Future Analysis
for Hypodermic Syringes by Type - Prefilled and Others
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-33

Table 89: Japanese Historic Review for Hypodermic Syringes
by Type - Prefilled and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-34

Table 90: Japanese 15-Year Perspective for Hypodermic
Syringes by Type - Percentage Breakdown of Dollar Sales for
Prefilled and Others Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-35

4. EUROPE III-36
A.Market Analysis III-36
Outlook III-36
Focus on Safety Fuels Demand for Prefilled Syringes III-36
Region-Wide Laws on Safety Syringes on the Cards III-37
Needlestick Statistics III-37
Table 91: Percentage of Needlestick Injuries by Different
Healthcare Personnel (2012) (includes corresponding
Graph/Chart) III-37

Table 92: Percentage of Needlestick Injuries by Different
Activities (2012) (includes corresponding Graph/Chart) III-37
Trend towards Injectable Drug Delivery: Rising Demand for
Syringes III-38
Table 93: European Market for Injectable Drug Delivery
Technologies (2013): Percentage Share Breakdown of Value
Sales by Region/Country (includes corresponding
Graph/Chart) III-38
Insulin Delivery Devices Market - An Insight III-38
Table 94: Diabetes and Population Statistics in Europe
(2013 and 2035) III-39

Table 95: European Population and Diabetes Prevalence
Statistics (2013E) - Select Regions with High Prevalence of
Diabetes for Age Groups (20-39, 40-59, and 60-79) and
Gender (includes corresponding Graph/Chart) III-39

Table 96: European Insulin Delivery Devices Market by
Segment (2013E): Percent Share Breakdown of Consumption for
Insulin Pens, Insulin Pumps, and Insulin Syringes (includes
corresponding Graph/Chart) III-40
B.Market Analytics III-41
Table 97: European Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Geographic Region
- France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-41

Table 98: European Historic Review for Syringes (Disposable
and Reusable) by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-42

Table 99: European 15-Year Perspective for Syringes
(Disposable and Reusable) by Geographic Region - Percentage
Breakdown of Dollar Sales for France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets for Years 2006, 2014
and 2020 (includes corresponding Graph/Chart) III-43

Table 100: European Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-44

Table 101: European Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-45

Table 102: European 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-46

Table 103: European Recent Past, Current and Future Analysis
for Hypodermic Syringes by Type - Prefilled and Others
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-47

Table 104: European Historic Review for Hypodermic Syringes
by Type - Prefilled and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-48

Table 105: European 15-Year Perspective for Hypodermic
Syringes by Type - Percentage Breakdown of Dollar Sales for
Prefilled and Others Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-49

4a. FRANCE III-50
Market Analysis III-50
Table 106: French Recent Past, Current and Future Analysis for
Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-50

Table 107: French Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-51

Table 108: French 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-52

4b. GERMANY III-53
A.Market Analysis III-53
Outlook III-53
Strategic Corporate Developments III-53
B. Braun Melsungen AG - A Key Player III-53
B.Market Analytics III-54
Table 109: German Recent Past, Current and Future Analysis for
Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-54

Table 110: German Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-55

Table 111: German 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-56

4c. ITALY III-57
A.Market Analysis III-57
Outlook III-57
Strategic Corporate Development III-57
B.Market Analytics III-58
Table 112: Italian Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-58

Table 113: Italian Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-59

Table 114: Italian 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-60

4d. THE UNITED KINGDOM III-61
A.Market Analysis III-61
Outlook III-61
Strategic Corporate Developments III-61
Smiths Medical International Limited - A Key Player III-61
B.Market Analytics III-63
Table 115: UK Recent Past, Current and Future Analysis for
Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-63

Table 116: UK Historic Review for Syringes (Disposable and
Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-64

Table 117: UK 15-Year Perspective for Syringes (Disposable
and Reusable) by Product Segment - Percentage Breakdown of
Dollar Sales for Anesthesia Syringes, Angiographic Syringes,
Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear
Syringes, Hypodermic Syringes, Insulin Syringes,
Intraligamentary Syringes, and Irrigating Syringes Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-65

4e. SPAIN III-66
Market Analysis III-66
Table 118: Spanish Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-66

Table 119: Spanish Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-67

Table 120: Spanish 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-68

4f. RUSSIA III-69
Market Analysis III-69
Table 121: Russian Recent Past, Current and Future Analysis
for Syringes (Disposable and Reusable) by Product Segment -
Anesthesia Syringes, Angiographic Syringes, Blood Gas
Syringes, Catheter Syringes, Dental Syringes, Ear Syringes,
Hypodermic Syringes, Insulin Syringes, Intraligamentary
Syringes, and Irrigating Syringes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-69

Table 122: Russian Historic Review for Syringes (Disposable
and Reusable) by Product Segment - Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-70

Table 123: Russian 15-Year Perspective for Syringes
(Disposable and Reusable) by Product Segment - Percentage
Breakdown of Dollar Sales for Anesthesia Syringes,
Angiographic Syringes, Blood Gas Syringes, Catheter
Syringes, Dental Syringes, Ear Syringes, Hypodermic
Syringes, Insulin Syringes, Intraligamentary Syringes, and
Irrigating Syringes Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-71

4g. REST OF EUROPE III-72
A.Market Analysis III-72
Outlook III-72
Strategic Corporate Developments III-72
Covidien (Ireland) - A Key Player III-72
B.Market Analytics III-73
Table 124: Rest of Europe Recent Past, Current and Future
Analysis for Syringes (Disposable and Reusable) by Product
Segment - Anesthesia Syringes, Angiographic Syringes, Blood
Gas Syringes, Catheter Syringes, Dental Syringes, Ear
Syringes, Hypodermic Syringes, Insulin Syringes,
Intraligamentary Syringes, and Irrigating Syringes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Analysis of the Global In Vitro Diagnostics Market

Analysis of the Global In Vitro Diagnostics Market

  • $ 10 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Slowing US and European Markets Demand Alignment with Global Market Needs Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of ...

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

  • $ 7 302
  • Industry report
  • August 2014
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for chemical and physical analysis equipment in different Asian countries. ...

Global Immunoassay Systems Market

September 2014 $ 4 950

Global Cholesterol Testing Market

September 2014 $ 4 950

1 Companies

Company Profiles

Roche Holding AG

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.